Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 3, 2008, Pages 1040-1045

  Oh, Jae Ho ^a   Park, Hyoun Hyang ^b   Do, Ki Young ^a   Han, Manhee ^b   Hyun, Dong Hun ^c   Kim, Chang Gyu ^c   Kim, Chang Hyeon ^c   Lee, Seung S ^b   Hwang, Sung Joo ^a   Shin, Sang Chul ^d   Cho, Cheong Weon ^a  

^a Chungnam National University   (South Korea)

^b Center for Ultramicrochemical Process Systems   (South Korea)

^c Daedeok Research Institute   (South Korea)

^d Chonnam National University   (South Korea)

Author keywords

Calcein; Delivery systems; Gel; Microneedle; Permeation

Indexed keywords

CALCEIN; POLYCARBONATE;

ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; FIRST PASS EFFECT; MALE; MATHEMATICAL MODEL; NEEDLE; NONHUMAN; RAT; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ALGORITHMS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; FLUORESCEINS; FLUORESCENT DYES; GELS; MALE; MODELS, STATISTICAL; NANOPARTICLES; NEEDLES; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION; SPECTROMETRY, FLUORESCENCE;

EID: 48149083798     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.02.009     Document Type: Article

References (23)

1. Kirjavainen M., Monkkonen J., Saukkosaari M., Valjakka-Koskela R., Kiesvaara J., and Urtti A. Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J. Control. Release 58 (1999) 1129-1144
2. Parsaee S., Sarbolouki M.N., and Parnianpour M. In-vitro release of diclofenac diethylammonium from lipid-based formulations. Int. J. Pharm. 241 (2002) 185-190
3. Ho H., Huang F.C., Sokoloski T.D., and Sheu M.T. The influence of cosolvents on the in-vitro percutaneous penetration of diclofenac sodium from a gel system. J. Pharm. Pharmacol. 46 (1994) 636-642
4. Shin S.C., Kim H.J., Oh I.J., Cho C.W., and Yang K.H. Development of tretinoin gels for enhanced transdermal delivery. Eur. J. Pharm. Biopharm. 60 (2005) 67-71
5. Crommelin D.J., Storm G., Verrijk R., De Leede L., Jiskoot W., and Hennink W.E. Shafting paradigms: biopharmaceuticals versus low molecular weight drugs. Int. J. Pharm. 266 1-2 (2003) 3-16
6. Ho R.J.Y., and Gibaldi M. Biotechnology and Biopharmaceuticals - Transforming Proteins and Genes into Drugs (2003), Wiley-liss, A John Wiley & Sons, Inc.
7. Henry S., McAllister D.V., Allen M.G., and Prausnitz M.R. Fabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 87 8 (1998) 922-925
8. Prausnitz M.R. Microneedles for transdermal drug delivery. Adv. Drug Deliv. Rev. 56 (2004) 581-587
9. Prausnitz M.R., Mikszta J.A., and Raeder-Devens J. Microneedles. In: Smith E.W., and Maibach H.I. (Eds). Percutaneous Penetration Enhancers (2006), CRC Press, Boca Raton, FL 239-256
10. Reed M.L., and Lye W.K. Microsystems for drug and gene delivery. Proc. IEEE 92 1 (2004) 56-75
11. Park J.H., Allen M.G., and Prausnitz M.R. Biodegrdable polymer microneedles: Fabrication, mechanics and transdermal drug delivery. J. Control. Release 104 (2005) 51-66
12. Verbaan F.J., Bal S.M., van den Berg D.J., Groenink W.H., Verpoorten H., Lüttge R., and Bouwstra J.A. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J. Control Release 117 (2007) 238-245
13. Park J.H., Allen M.G., and Prausnitz M.R. Polymer microneedles for controlled-release drug delivery. Pharm. Res. 23 (2006) 1008-1019
14. Ito Y., Hagiwara E., Saeki A., Sugioka N., and Takada K. Feasibility of microneedles for percutaneous absorption of insulin. Eur. J. Pharm. Sci. 29 (2006) 82-88
15. Gill H.S., and Prausnitz M.R. Coated microneedles for transdermal delivery. J. Control. Release 117 (2007) 227-237
16. Martanto W., Davis S.P., Holiday N.R., Wang J., Gill H.S., and Prausnitz M.R. Transdermal delivery of insulin using microneedles in vivo. Pharm. Res. 21 6 (2004) 947-952
17. Cormier M., Johnson B., Americ M., Nyam K., Libiran L., Zhang D.D., and Daddona P. Transdermal delivery of desmopressin using a coated microneedle array patch system. J. Control. Release 97 3 (2004) 503-511
18. Lin W., Cormier M., Samiee A., Griffin A., Johnson B., Teng C.L., Hardee G.E., and Daddona P.E. Transdermal delivery of antisense oligonucleotides with microprojection patch (macroflux) technology. Pharm. Res. 18 912 (2001) 1789-1793
19. Chabri F., Bouris K., Jones T., Barrow D., Hann A., Allender C., Brain K., and Birchall J. Microfabricated silicon microneedles for nonviral cutaneous gene delivery. Br. J. Dermatol. 150 5 (2004) 869-877
20. Mikszta J.A., Alarcon J.B., Brittingham J.M., Sutter D.E., Pettis R.J., and Harvey N.G. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat. Med. 8 4 (2002) 415-419
21. Mikszta J.A., Sullivan V.J., Dean C., Waterston A.M., Alarcon J.B., Dekker III J.P., Brittingham J.M., Huang J., Hwang C.R., Ferriter M., Jiang G., Mar K., Saikh K.U., Stiles B.G., Roy C.J., Ulrich R.G., and Harvey N.G. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J. Infect. Dis. 191 2 (2005) 278-288
22. Dean C.H., Alarcon J.B., Waterston A.M., Draper K., Early R., Guirakhoo F., Monath T.P., and Mikszta J.A. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccines against Japanese encephalitis (ChimeriVaxTM-JE) in non-human primates. Hum. Vaccines 1 3 (2005) 106-111
23. Han M.H., Hyun D.H., Park H.H., Lee S.S., Kim C.H., and Kim C.G. Anoble fabrication process for out-of-plane microneedle sheets of biocompatible polymer. J. Micromech. Microeng. 17 (2007) 1184-1191